# Prevention of Recurrence of Herpes Simplex in Autoimmune Rheumatic Diseases

> **NCT07341386** · PHASE4 · NOT_YET_RECRUITING · sponsor: **University of Sao Paulo General Hospital** · enrollment: 62 (estimated)

## Conditions studied

- Autoimmune Rheumatic Diseases
- Recurrent Herpes Simplex
- Prevention

## Interventions

- **DRUG:** Acyclovir (ACV)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07341386
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2027-04-01
- **Final completion:** 2028-04-01
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2026-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07341386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07341386, "Prevention of Recurrence of Herpes Simplex in Autoimmune Rheumatic Diseases". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07341386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*